Merck & Co. is putting down $30 million cash to buy Yale spinout Modifi Biosciences, a deal that includes a preclinical asset ...

Shawn Li, principal scientist at Merck & Co., known as MSD outside the Unites States and Canada, talked about the importance ...

Merck has been in pursuit of eligible candidates that could ... Japan's Daiichi Sankyo to jointly develop three of its ...

This uptick in stock price started in May after the company reported that its lead pipeline drug ivonescimab outdid Merck’s MRK blockbuster oncology drug Keytruda in a head-to-head phase III HARMONi-2 ...

We recently compiled a list of the 8 Most Undervalued Value Stocks To Buy According To Analysts. In this article, we are ...

Roche’s chronic cough program has sputtered to a halt. The drugmaker, which axed the program after the drug candidate ...

Report on how AI is driving market transformation - The Oncology Market in India  size is estimated to grow by USD 1.49 ...

Jefferies analyst Akash Tewari has assigned their bullish stance on ARVN stock, giving a Buy rating yesterday. Akash Tewari’s rating is ...

Chairman of the Senate Committee on Health, Education, Labor, and Pensions (HELP), today joined President Joe Biden in Concord, New Hampshire at the New Hampshire Technical Institute for an event on ...

Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...

Edward’s Syndrome Treatment MarketThe global Edward’s syndrome treatment market is set for significant growth, with a projected market value of USD 7.98 Billion by 2033, according to a newly released ...

I wasn't bothered when folks wanted to administer ivermectin to themselves or their loved ones when COVID was at its peak, ...